Ligand validation:4D13

MPD: (4S)-2-METHYL-2,4-PENTANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4D13_MPD_A_1298	21%	57%	0.185	0.794	0.55	1.07	-	-	1	0	100%	1
4CW2_MPD_A_1304	16%	51%	0.201	0.77	0.49	1.4	-	2	3	0	100%	0.5
4CW6_MPD_A_1303	14%	55%	0.186	0.732	0.42	1.29	-	1	1	0	100%	0.5
4D12_MPD_A_1302	4%	77%	0.265	0.637	0.27	0.64	-	-	3	0	100%	0.5
4QSR_MPD_A_1204	96%	63%	0.078	0.99	0.55	0.84	-	-	0	0	100%	1
3BUI_MPD_A_1048	95%	60%	0.069	0.974	0.57	0.95	-	-	0	1	100%	1
4WPG_MPD_A_301	95%	48%	0.056	0.958	0.43	1.57	-	3	1	0	100%	1
6JOW_MPD_B_901	93%	70%	0.066	0.962	0.34	0.77	-	-	3	0	100%	1
8PO9_MPD_D_910	93%	86%	0.081	0.976	0.3	0.42	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.